Rabies

Rabies is a fatal, zoonotic, viral encephalomyelitis caused by neurotropic viruses of the genus Lyssavirus, family Rhabdoviridae. The disease affects all mammals, including dogs and cats, and is characterized by progressive neurological dysfunction leading to death. Rabies is a classic 'neglected zoonotic disease' and remains a major public health concern worldwide, particularly in regions where dog-mediated rabies is endemic. The disease presents in two main clinical forms: the furious (encephalitic) form and the paralytic (dumb) form. The incubation period is highly variable, ranging from weeks to months, depending on the viral dose, route of inoculation, and host factors. Once clinical signs appear, the disease is almost invariably fatal, with no effective treatment available. Rabies is a notifiable disease, and its diagnosis has profound implications for public health and animal welfare.

The causative agents are RNA viruses belonging to the genus Lyssavirus, family Rhabdoviridae. The most important species is Rabies lyssavirus (RABV), which is responsible for the vast majority of mammalian rabies cases. Other lyssaviruses (e.g., European bat lyssaviruses 1 and 2, Australian bat lyssavirus) can also cause rabies-like disease but are less common. The virus is enveloped, bullet-shaped, and contains a single-stranded, negative-sense RNA genome encoding five structural proteins: nucleoprotein (N), phosphoprotein (P), matrix protein (M), glycoprotein (G), and RNA-dependent RNA polymerase (L). The G protein is the major antigenic determinant and is responsible for receptor binding and membrane fusion. The virus is highly neurotropic, preferentially infecting neurons. Transmission occurs primarily through the bite of a rabid animal, with saliva containing the virus. Other routes include contamination of mucous membranes or broken skin with infectious saliva, and rarely, aerosol transmission in caves with high bat densities. The virus is fragile in the environment and is inactivated by heat, ultraviolet light, and common disinfectants.

Rabies has a worldwide distribution, with the exception of a few countries that have achieved freedom from dog-mediated rabies (e.g., Australia, Japan, the United Kingdom, and parts of Western Europe). In many developing regions, particularly in Asia and Africa, canine rabies is endemic, with dogs serving as the primary reservoir and vector. In North America and Europe, wildlife reservoirs such as raccoons, skunks, foxes, and bats are more important. Domestic dogs and cats are incidental hosts but can transmit the virus to humans. The disease affects all breeds and ages, but unvaccinated, free-roaming animals are at highest risk. There is no sex predilection. The incidence is higher in rural areas where vaccination coverage is low. Seasonal patterns may occur, with peaks during warmer months when animal interactions increase. In endemic areas, the estimated annual human mortality is tens of thousands, with dogs responsible for up to 99% of human rabies deaths.

After inoculation via a bite, the virus replicates locally in muscle cells at the site of entry. It then binds to nicotinic acetylcholine receptors at the neuromuscular junction and enters peripheral nerves. The virus travels centripetally along axons via retrograde axonal transport, reaching the spinal cord and brain. Once in the central nervous system (CNS), the virus replicates rapidly in neurons, causing neuronal dysfunction and apoptosis. The virus then spreads centrifugally along peripheral nerves to various organs, including the salivary glands, where it is shed in saliva. The incubation period is typically 2-8 weeks in dogs and cats, but can be longer. The pathogenesis involves evasion of the host immune response, as the virus suppresses interferon signaling and induces neuronal apoptosis. The encephalitis is characterized by perivascular lymphocytic infiltration, gliosis, and the presence of Negri bodies (eosinophilic cytoplasmic inclusions) in neurons, particularly in the hippocampus and Purkinje cells. The furious form is associated with excessive neuronal excitation, while the paralytic form results from neuronal destruction and dysfunction.

The primary risk factor for rabies is lack of vaccination. Unvaccinated animals, especially those with outdoor access, are at high risk. Young animals (<1 year) may be more susceptible due to incomplete vaccination protocols. Immunosuppression, whether due to concurrent disease or drug therapy, may increase susceptibility. Environmental factors such as high population density of reservoir species, wildlife encroachment, and inadequate stray animal control contribute to transmission. Human behavior, such as failure to report bites and lack of post-exposure prophylaxis, also influences the epidemiology. In endemic areas, poverty and limited access to veterinary care are significant predisposing factors.

The clinical course of rabies is divided into three phases: prodromal, furious, and paralytic. The prodromal phase lasts 1-3 days and is characterized by subtle behavioral changes: anxiety, restlessness, hiding, and increased affection or irritability. The furious form (encephalitic) is more common in dogs and is marked by extreme agitation, aggression, disorientation, seizures, and hypersalivation. Animals may attack inanimate objects and show signs of photophobia and hyperesthesia. The paralytic form (dumb) is more common in cats and is characterized by progressive paralysis, starting with the limbs and spreading to the head and throat, leading to dysphagia, drooling, and a dropped jaw. In both forms, death occurs due to respiratory paralysis, usually within 7-10 days of clinical onset. Other signs include fever, vomiting, and altered vocalization. It is crucial to note that clinical signs are highly variable and can mimic other neurological diseases.

Differential diagnoses for rabies include: (1) Canine distemper virus infection, which presents with fever, respiratory signs, and neurological signs, but typically has a longer course and may include myoclonus; (2) Toxoplasmosis, which can cause encephalitis and behavioral changes, but is often associated with systemic signs and can be diagnosed by serology or PCR; (3) Neosporosis, similar to toxoplasmosis, causing progressive paralysis in dogs; (4) Pseudorabies (Aujeszky's disease), which causes intense pruritus and self-mutilation, primarily in pigs and occasionally in dogs; (5) Hepatic encephalopathy, which can cause behavioral changes and seizures, but is associated with liver disease and elevated ammonia; (6) Lead poisoning, which causes gastrointestinal and neurological signs, with basophilic stippling on blood smear; (7) Brain tumors, which can cause progressive neurological deficits, but are usually more gradual in onset; (8) Meningitis/encephalitis of other infectious etiologies (e.g., bacterial, fungal, protozoal) or immune-mediated origin. Definitive diagnosis of rabies requires laboratory testing, as clinical signs are not pathognomonic.

The diagnostic algorithm for rabies begins with a thorough history and physical examination, with emphasis on vaccination status, exposure to potentially rabid animals, and progression of neurological signs. If rabies is suspected, the animal should be humanely euthanized to minimize risk to humans and other animals, and the head should be submitted for laboratory testing. The gold standard diagnostic test is the direct fluorescent antibody (DFA) test on brain tissue (e.g., hippocampus, brainstem, cerebellum). This test detects viral antigen and is highly sensitive and specific. Confirmatory tests include virus isolation in cell culture or mouse inoculation, and molecular techniques such as reverse transcription polymerase chain reaction (RT-PCR) on brain tissue or saliva. In some cases, ante-mortem testing can be performed on saliva, cerebrospinal fluid (CSF), or skin biopsies from the nuchal area, but these have lower sensitivity and are not recommended for definitive diagnosis. The algorithm emphasizes that rabies should be considered in any animal with acute, progressive encephalopathy, especially if unvaccinated or with a history of exposure.

Routine laboratory findings in rabies are non-specific. Complete blood count may show mild leukocytosis or leukopenia. Serum biochemistry may reveal mild elevations in liver enzymes and muscle enzymes due to seizures or trauma. Cerebrospinal fluid analysis may show mild lymphocytic pleocytosis and elevated protein, but these findings are not specific. Definitive diagnosis relies on detection of viral antigen or nucleic acid. The DFA test on brain tissue is the standard. RT-PCR can detect viral RNA in brain tissue, saliva, and CSF. Serological tests (e.g., virus neutralization) are used for surveillance and vaccine response assessment, not for diagnosis of clinical disease. Histopathology of brain tissue may reveal Negri bodies, but these are not always present.

Imaging studies are not typically performed in suspected rabies cases due to the risk of human exposure and the need for rapid euthanasia. However, if imaging is performed for other reasons, magnetic resonance imaging (MRI) of the brain may show non-specific changes such as T2 hyperintensities in the brainstem, hippocampus, and spinal cord, reflecting inflammation and edema. Computed tomography (CT) is usually unremarkable. Imaging is not diagnostic for rabies and is primarily used to rule out other structural causes of neurological signs.

Cytological examination of cerebrospinal fluid may show a mild lymphocytic pleocytosis. Histopathological examination of brain tissue is the cornerstone of post-mortem diagnosis. The characteristic finding is the Negri body, an eosinophilic, intracytoplasmic inclusion body found in neurons, especially in the hippocampus (Ammon's horn), cerebral cortex, and Purkinje cells of the cerebellum. However, Negri bodies are not always present, and their absence does not rule out rabies. Other histopathological changes include perivascular lymphocytic cuffing, gliosis, and neuronal necrosis. Immunohistochemistry using anti-rabies antibodies can confirm the presence of viral antigen in formalin-fixed tissues.

There is no effective treatment for clinical rabies in animals. The disease is universally fatal once clinical signs appear. Therefore, the primary approach is prevention through vaccination. In the event of a suspected exposure, immediate post-exposure prophylaxis is recommended for humans, but for animals, the decision to euthanize or quarantine depends on local regulations and vaccination status. Unvaccinated animals exposed to a rabid animal should be euthanized immediately. Vaccinated animals with a documented history of vaccination should be revaccinated immediately and observed for 45 days. Supportive care is not recommended for clinical cases due to the zoonotic risk and poor prognosis. In some experimental settings, the Milwaukee protocol has been attempted in humans, but it is not applicable to animals.

The prognosis for rabies is grave. Once clinical signs develop, the disease is almost 100% fatal. The duration of clinical illness is typically 1-10 days, with death due to respiratory paralysis. There are no reported cases of survival in domestic animals. The prognosis is influenced by the viral strain, dose, and site of inoculation, but these factors do not alter the outcome. Therefore, the prognosis is uniformly poor, and euthanasia is recommended to prevent suffering and zoonotic transmission.

For animals that have been exposed to rabies but are vaccinated and under observation, a strict quarantine period of 45 days is recommended. During this period, the animal should be monitored daily for any signs of illness. If the animal develops signs suggestive of rabies, it should be euthanized and tested. For animals that have been vaccinated, booster vaccination is recommended immediately after exposure. In endemic areas, routine vaccination of dogs and cats is essential, with boosters every 1-3 years depending on the vaccine and local regulations. Public health authorities should be notified of any confirmed or suspected cases.

Pearls: (1) Rabies should be considered in any animal with acute, progressive neurological signs, especially if unvaccinated or with a history of exposure. (2) The furious form is more common in dogs, while the paralytic form is more common in cats. (3) Hypersalivation and dysphagia are common signs due to pharyngeal paralysis. (4) The DFA test on brain tissue is the gold standard for diagnosis. (5) Vaccination is the cornerstone of prevention. Pitfalls: (1) Do not attempt to treat a suspected rabid animal; the risk to humans is too high. (2) Do not rely on clinical signs alone; they can mimic other diseases. (3) Do not delay euthanasia and testing if rabies is suspected. (4) Avoid handling the animal without proper protective equipment. (5) Do not forget to report the case to public health authorities.

There is no antiviral drug approved for the treatment of rabies in animals. Post-exposure prophylaxis in humans involves rabies immune globulin (RIG) and a series of rabies vaccines. In animals, the only intervention is vaccination. For pre-exposure prophylaxis, inactivated rabies vaccines are available for dogs and cats. The recommended dosage is 1 mL administered subcutaneously or intramuscularly, with a booster at 1 year of age and then every 1-3 years depending on the vaccine label and local regulations. In the event of a suspected exposure, a booster vaccination is recommended for previously vaccinated animals. For unvaccinated animals, euthanasia is recommended. There are no other drug protocols for rabies.

The literature on rabies is extensive. Key consensus guidelines include the World Health Organization (WHO) recommendations for rabies prevention and control, which emphasize dog vaccination as the most cost-effective strategy. The World Organisation for Animal Health (OIE) provides standards for rabies diagnosis and vaccine quality. Studies have demonstrated that canine rabies vaccination programs can eliminate dog-mediated human rabies. The direct fluorescent antibody test is the gold standard for diagnosis, with high sensitivity and specificity. Molecular techniques such as RT-PCR are increasingly used for rapid diagnosis and epidemiological surveillance. The pathogenesis of rabies involves immune evasion and neuronal apoptosis, as reviewed in recent publications. The Milwaukee protocol, which involves therapeutic coma and antiviral drugs, has been attempted in a few human cases but has not been successful in animals. Overall, the evidence strongly supports vaccination as the primary preventive measure, and there is no effective treatment for clinical disease.